Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
viernes, noviembre 20
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Revolution Medicines Inc
RVMD
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$159.43
-0.39
-0.24%
al cierre: Nov 19, 4:00 PM EST
$158.00
-1.43
-0.9%
After hour: 7:59 PM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Revolution Medicines Financials
Revolution Medicines (RVMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Nasdaq 100 Jumps 2.8% as CoreWeave, Nvidia Climb: Stock Market Today
CoreWeave's 25.1% surge revived the AI trade, lifting chipmakers, memory and power stocks, while Nvidia shrugged off a Baird downgrade.
Piero Cingari
PRO
Revolution Medicines Q3 EPS $(1.90) Beats $(2.42) Estimate, Sales $197.559M May Not Be Comparable To $23.495M Estimate
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(1.90) per share which beat the analyst consensus estimate of $(2.42) by 21.49 percent. This is a 18.01 percent decrease over losses of $(1.61) per share
Benzinga Newsdesk
ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test
ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber Technologies, CVS Health
Benzinga Insights
Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week
Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.
Piero Cingari
PRO
Revolution Medicines Q2 EPS $(3.06) Misses $(1.98) Estimate
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(3.06) per share which missed the analyst consensus estimate of $(1.98) by 54.55 percent. This is a 133.59 percent decrease over losses of $(1.31) per
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights